Stories
Sedemac Sees Rs 1,469 Cr Action; PE Investors Exit FirstCry, NephroPlus; HDFC MF Buys PB Fintech
- •Sedemac Mechatronics witnessed a block deal of 48.8 lakh shares worth Rs 1,469 crore, with PE investors exiting and sovereign funds like GIC and Monetary Authority of Singapore, along with domestic MFs, buying in.
- •NewQuest Asia Investments sold 1.15 crore shares of Brainbees Solutions (FirstCry) worth Rs 202 crore, while Goldman Sachs acquired 68 lakh shares for Rs 119 crore.
- •Edoras Investment Holdings divested 25 lakh shares of Nephrocare Health Services (NephroPlus) for Rs 178 crore, with Polar Capital's Healthcare Opportunities Fund purchasing 25.46 lakh shares for Rs 179.5 crore.
- •HDFC Mutual Fund bought 25 lakh shares of PB Fintech for Rs 320.6 crore at Rs 1,282.30 apiece, amidst a 36% stock crash due to proposed IRDAI changes.
- •Hoechst GmbH transferred 35 lakh shares of Aventis Pharma worth Rs 1,068 crore to Sanofi Healthcare India, an intra-group promoter reshuffle.
Key Questions Answered
PE investors A91 Emerging Fund II and Xponentia Capital's affiliated funds exited part of their holdings in Sedemac Mechatronics. Buyers included sovereign funds like the Government of Singapore (GIC) and the Monetary Authority of Singapore, alongside several domestic mutual funds and international investment firms such as T Rowe Price and Franklin Templeton.
PB Fintech stock crashed 36% following proposed changes to insurance distribution commissions by the IRDAI. Amidst the drop, HDFC Mutual Fund bought 25 lakh shares worth about Rs 320.6 crore at a price of Rs 1,282.30 apiece.
In FirstCry, pre-IPO backer NewQuest Asia Investments sold 1.15 crore shares while Goldman Sachs bought 68 lakh shares. In NephroPlus, existing investor Edoras Investment Holdings sold about 25 lakh shares, with Polar Capital's Healthcare Opportunities Fund emerging as a standout buyer picking up 25.46 lakh shares.
